ABBV
AbbVie Inc.
Stock
$263.29−2.99 (−1.12%)Close Sep 29, 2026
| Selling, general and administrative (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $14.7B | +0.5% | 4.4% | 8.2% |
| Selling, general and administrative (TTM) | $14.7B |
|---|---|
| YoY | +0.5% |
| 5-year CAGR | 4.4% |
| 10-year CAGR | 8.2% |
Selling, general and administrative
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $14.0B | −5.0% |
| 2024 | $14.8B | +14.6% |
| 2023 | $12.9B | −15.6% |
| 2022 | $15.3B | +23.6% |
| 2021 | $12.3B | +9.3% |
| 2020 | $11.3B | +62.8% |
| 2019 | $6.9B | −6.2% |
| 2018 | $7.4B | +17.5% |
| 2017 | $6.3B | +7.0% |
| 2016 | $5.9B | −7.9% |
| 2015 | $6.4B | −17.3% |
| 2014 | $7.7B | +44.3% |
| 2013 | $5.4B | +7.3% |
| 2012 | $5.0B | −15.4% |
| 2011 | $5.9B | — |